Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AlloDerm vs sCTG for Peri-Implant Mucosa Thickness
NCT02450383Phase 4Completed
- Sponsor
- University of Iowa
- Start
- Jan 2015
- Primary completion
- Sep 2016
- Modality
- Implantable Devices
- Countries
- 1
01
Overview
A Phase 4 trial of AlloDerm in Peri-implant marginal mucosa defect (PMMD), sponsored by University of Iowa. Started Jan 2015; status: completed.
02
Drugs
AlloDerm
03
Conditions
Peri-implant marginal mucosa defect (PMMD)
Beyond the preview
Go deeper on NCT02450383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02450383.